Vaccine efficacy 30% for BNT162b2(Pfizer) and 11 percent for mRNA-1273 (Moderna) against any SARS-CoV-2 infection.
When COVID case counts are low, relax but prepare for future outbreaks: speaker
By
Kimberly Bonvissuto
Mar 24, 2022
It’s OK to relax a little and take off that mask when community COVID-19 transmission rates are low. But an epidemiologist says that that’s also the time to prepare.
Effectiveness of Ad26.COV2.S vaccine stable for six months
Mar 22, 2022
A single dose of the Johnson & Johnson vaccine was 74% and 81% effective for preventing COVID-19 infection and hospitalizations, respectively, in the U.S. before and during delta variant surge.
No myocarditis recurrence after SARS-CoV-2 vaccination
Mar 22, 2022
No cases of myocarditis were seen after vaccination in small study with 55 patients with a history of myocarditis who were vaccinated.
Risk for shoulder conditions small after vaccination in deltoid muscle
Mar 21, 2022
The incidence of shoulder conditions per 10,000 vaccinations was 1.22 for adults (age 18 years or older) and 0.05 for children (age 3 to 17 years).
COVID-19 vaccines not tied to immune-mediated neurological events
Mar 21, 2022
But increased risks for Bell palsy, encephalomyelitis and Guillain-Barré syndrome were observed following SARS-CoV-2 infection.
Moderna asks FDA to approve second booster for all adults
Mar 18, 2022
The Moderna request covers all adults to give federal health officials the freedom to determine who should get a second booster.
Risk for blood clots after COVID-19 vaccination explored
Mar 11, 2022
Two studies show an increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S.
COVID-19 vaccination coverage higher in urban versus rural counties
Mar 08, 2022
Completion of the primary series was higher in urban than rural counties. Receipt of the booster was low in both urban and rural counties.
In reversal, WHO now supports COVID-19 boosters
Mar 08, 2022
Several studies show that booster doses help restore weakening immunity and protect against severe COVID-19.